# Eyewire News: The Podcast

Page: https://stenobird.com/podcast/eyewire-news-the-podcast-7055536
Text version: https://stenobird.com/podcast/eyewire-news-the-podcast-7055536.md
RSS feed: https://feeds.megaphone.fm/eyewire
Author: Bryn Mawr Communications (BMC)
Episodes: 92

## Resource

Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.

## Machine-readable

JSON: https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536
Markdown: https://stenobird.com/podcast/eyewire-news-the-podcast-7055536.md

## Episodes
- [Future of Posterior Therapeutics](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/future-of-posterior-therapeutics) — 2026-05-13T18:09:00+00:00
- [Bayer Acquires Perfuse in $2.45 Billion Deal](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/bayer-acquires-perfuse-in-2-45-billion-deal) — 2026-05-06T18:40:00+00:00
- [How Ophthalmology Strategics are Rewriting the Playbook](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/how-ophthalmology-strategics-are-rewriting-the-playbook) — 2026-04-29T19:00:00+00:00
- [Glaukos Issued J-Code for Recently Launched Epioxa](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/glaukos-issued-j-code-for-recently-launched-epioxa) — 2026-04-22T19:27:00+00:00
- [Breaking News from the ASCRS Meeting in Washington DC](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/breaking-news-from-the-ascrs-meeting-in-washington-dc) — 2026-04-15T20:39:00+00:00
- [More than 3 Million Bottles of Eye Drops Recalled](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/more-than-3-million-bottles-of-eye-drops-recalled) — 2026-04-08T16:53:00+00:00
- [Biogen Enters GA Treatment Market After Major Acquisition](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/biogen-enters-ga-treatment-market-after-major-acquisition) — 2026-04-01T19:06:00+00:00
- [Interview with ASCRS Executive Director Steve Speares](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/interview-with-ascrs-executive-director-steve-speares) — 2026-03-25T20:00:00+00:00
- [Alcon and Lensar Call Off Merger](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/alcon-and-lensar-call-off-merger) — 2026-03-18T19:31:00+00:00
- [FDA Agrees to Review Phentolamine for Presbyopia](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/fda-agrees-to-review-phentolamine-for-presbyopia) — 2026-03-04T21:07:00+00:00
- [Zeiss Launches App to Improve Workflow](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/zeiss-launches-app-to-improve-workflow) — 2026-02-25T20:51:00+00:00
- [Ocular Releases Phase 3 Data for Wet AMD Candidate Axpaxli](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/ocular-releases-phase-3-data-for-wet-amd-candidate-axpaxli) — 2026-02-18T20:08:00+00:00
- [Study: Metformin May Lower AMD Progression](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/study-metformin-may-lower-amd-progression) — 2026-02-11T20:45:00+00:00
- [First Dual-Agent Eye Drop for Presbyopia Approved](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/first-dual-agent-eye-drop-for-presbyopia-approved) — 2026-02-04T20:01:00+00:00
- [FDA Approves Label Supplement for iDose TR](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/fda-approves-label-supplement-for-idose-tr) — 2026-01-28T20:00:00+00:00
- [Rayner Launches New Phaco System](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/rayner-launches-new-phaco-system) — 2026-01-21T21:02:00+00:00
- [Moorfields Researchers Reveal Promising Treatment for Hypotony](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/moorfields-researchers-reveal-promising-treatment-for-hypotony) — 2026-01-14T20:21:00+00:00
- [Staar Terminates Merger with Alcon](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/staar-terminates-merger-with-alcon) — 2026-01-07T20:41:00+00:00
- [2025 Year in Review - Part 2](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/2025-year-in-review-part-2) — 2025-12-31T05:00:00+00:00
- [2025 Year in Review - Part 1](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/2025-year-in-review-part-1) — 2025-12-24T05:00:00+00:00
- [Update on Reproxalap PDUFA Timing](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/update-on-reproxalap-pdufa-timing) — 2025-12-17T20:44:00+00:00
- [New Glaucoma Technologies Advance in Clinical Development](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/new-glaucoma-technologies-advance-in-clinical-development) — 2025-12-10T20:32:00+00:00
- [Eylea HD Approved for RVO and Extended Dosing](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/eylea-hd-approved-for-rvo-and-extended-dosing) — 2025-12-03T20:39:00+00:00
- [Leaders Discuss Emerging Technologies in Glaucoma](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/leaders-discuss-emerging-technologies-in-glaucoma) — 2025-11-26T16:30:00+00:00
- [Live Coverage of B+L Investor Day](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/live-coverage-of-b-l-investor-day) — 2025-11-18T21:40:00+00:00

## Actions

Episode pages expose an explicit `request_transcript` action. A page view does not automatically enqueue transcription.